kontan.co.id
banner langganan top
| : WIB | INDIKATOR |
  • LQ451.014,86   25,80   2.61%
  • EMAS954.000 0,21%
  • RD.SAHAM -0.06%
  • RD.CAMPURAN -0.04%
  • RD.PENDAPATAN TETAP -0.32%

Malaysia's Pharmaniaga signs COVID vaccine agreement with China's Sinovac


Selasa, 12 Januari 2021 / 13:48 WIB
Malaysia's Pharmaniaga signs COVID vaccine agreement with China's Sinovac
ILUSTRASI. A man works in a laboratory of Chinese vaccine maker Sinovac Biotech. REUTERS/Thomas Peter


Sumber: Reuters | Editor: Herlina Kartika Dewi

KONTAN.CO.ID - KUALA LUMPUR. Malaysia Pharmaniaga Bhd has signed an agreement with China's Sinovac to purchase ready-to-fill COVID-19 vaccines and later to manufacture the vaccine domestically, it said on Tuesday.

Pharmaniaga said in a filing to the bourse that the company will carry out a fill-and-finish process of the vaccine in Malaysia, and will subsequently enter into local manufacturing, under license from Sinovac for its technology and know-how.

"This will also help Pharmaniaga in long-term partnerships, including technology transfer to grow the sector in Malaysia," the company said.

Malaysia has been in talks to secure a total of 23.9 million doses of COVID-19 vaccines from Sinovac and another Chinese manufacturer CanSino Biologics, and from Russia's Gamaleya Institute, the maker of the Sputnik V vaccine.

The Southeast Asian nation has also procured coronavirus vaccines from U.S. and German drugmakers Pfizer and BioNTech, as well as British-Swedish biopharmaceutical firm AstraZeneca PLC. 

Selanjutnya: Raja Malaysia umumkan keadaan darurat, untuk mengekang penyebaran Covid-19

 




TERBARU
Terpopuler
Certified Supply Chain Analyst (CSCA) Batch 7 Financial Modeling Fundamental

[X]
×